Sheaff Brock Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-5,356
Closed -$743K – 475
2024
Q1
$743K Hold
5,356
– – 0.05% 232
2023
Q4
$665K Buy
+5,356
New +$547K 0.05% 228
2020
Q3
– Sell
-5,440
Closed -$551K – 476
2020
Q2
$551K Buy
+5,440
New +$487K 0.05% 209
2020
Q1
– Sell
-6,000
Closed -$328K – 432
2019
Q4
$328K Sell
6,000
-400
-6% -$19K 0.03% 322
2019
Q3
$239K Buy
+6,400
New +$249K 0.03% 370

Other funds holding DXCM

Sheaff Brock Investment Advisors's DXCM Position: Q2 2024 in Review

Sheaff Brock Investment Advisors sold out of DexCom (DXCM) in Q2 2024, closing a stake of 5,356 shares — an estimated $743K sold.

Sheaff Brock Investment Advisors first reported a position in DXCM in Q3 2019 and held it in 5 quarters. The position peaked at $743K in Q1 2024. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Sheaff Brock Investment Advisors reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 5,356 DexCom shares in Q2 2024, an estimated $743K.
  • Sheaff Brock Investment Advisors first reported a position in DexCom in Q3 2019 and held it in 5 quarters.
  • Sheaff Brock Investment Advisors's DexCom position peaked at $743K in Q1 2024.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Sheaff Brock Investment Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.